Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Redox Homeostasis in Thyroid Cancer: Implications in Na+/I- Symporter (NIS) Regulation. | Int J Mol Sci | 2022 | 35682803 | PubTator, text mining | PubMed |
| Thyroid Dysfunction and COVID-19: The Emerging Role of Selenium in This Intermingled Relationship. | Int J Environ Res Public Health | 2022 | 35682497 | PubTator, text mining | PubMed |
| Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected. | Biomark Res | 2022 | 35672804 | PubTator, text mining | PubMed |
| Identification of the Active Compound of Liu Wei Di Huang Wan for Treatment of Gestational Diabetes Mellitus via Network Pharmacology and Molecular Docking. | J Diabetes Res | 2022 | 35669396 | PubTator, text mining | PubMed |
| A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer. | Redox Biol | 2022 | 35667246 | PubTator, text mining | PubMed |
| Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action. | Inflammopharmacology | 2022 | 35665873 | PubTator, text mining | PubMed |
| The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance. | Front Mol Biosci | 2022 | 35664671 | PubTator, text mining | PubMed |
| Nutrition, Epigenetics, and Major Depressive Disorder: Understanding the Connection. | Front Nutr | 2022 | 35662945 | PubTator, text mining | PubMed |
| A new look at the role of nitric oxide in preeclampsia: Protein S-nitrosylation. | Pregnancy Hypertens | 2022 | 35660510 | PubTator, text mining | PubMed |
| Exposure of human cerebral microvascular endothelial cells hCMEC/D3 to laminar shear stress induces vascular protective responses. | Fluids Barriers CNS | 2022 | 35658915 | PubTator, text mining | PubMed |
| A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma. | Cancer Res | 2022 | 35657206 | PubTator, text mining | PubMed |
| Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension. | Front Med (Lausanne) | 2022 | 35646965 | PubTator, text mining | PubMed |
| Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma. | Front Oncol | 2022 | 35646635 | PubTator, text mining | PubMed |
| Identification of Context-Specific Fitness Genes Associated With Metabolic Rearrangements for Prognosis and Potential Treatment Targets for Liver Cancer. | Front Genet | 2022 | 35646101 | PubTator, text mining | PubMed |
| Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways. | Front Pharmacol | 2022 | 35645817 | PubTator, text mining | PubMed |
| Role of Phytochemicals in Skin Photoprotection via Regulation of Nrf2. | Front Pharmacol | 2022 | 35645796 | PubTator, text mining | PubMed |
| Redox regulation by TXNRD3 during epididymal maturation underlies capacitation-associated mitochondrial activity and sperm motility in mice. | J Biol Chem | 2022 | 35643315 | PubTator, text mining | PubMed |
| Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer. | Breast Cancer Res Treat | 2022 | 35639264 | PubTator, text mining | PubMed |
| Ribosome stalling during selenoprotein translation exposes a ferroptosis vulnerability. | Nat Chem Biol | 2022 | 35637349 | PubTator, text mining | PubMed |
| Synthesis, Biological Activity, and Molecular Modelling Studies of Naphthoquinone Derivatives as Promising Anticancer Candidates Targeting COX-2. | Pharmaceuticals (Basel) | 2022 | 35631366 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=56